To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Oral Cancer: Diagnosis
Wednesday 27th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people diagnosed with mouth cancer in the last twelve months.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The information requested is not available for the last twelve months. The most recent data available from 2021 shows 9,018 people were diagnosed with mouth cancer in England. Further information is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2021---summary-counts-only


Written Question
Human Papillomavirus: Vaccination
Tuesday 26th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to encourage the uptake of HPV vaccinations in schools.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

National Health Service Commissioned School Aged Immunisation Service providers have robust catch-up plans in place for the adolescent human papillomavirus (HPV) vaccination programme based on population need, utilising opportunities from the move to one dose in September 2023.

The UK Health Security Agency (UKHSA) works closely with several charities to develop resources that can be used to raise awareness of HPV. UKHSA also publishes annual statistics to support local NHS teams in developing plans to improve HPV uptake and reduce inequalities.

NHS England has improved digital communications on vaccinations, including expanding the NHS app, and improved vaccine access outside of schools through community clinics at convenient times and locations. UKHSA produces a number HPV resources which are available at the following link:

https://www.gov.uk/government/collections/hpv-vaccination-programme

Other materials are available on the UKHSA Health Publications website in a range of language and accessible formats, which are available at the following link:

https://www.healthpublications.gov.uk/Home.html


Written Question
Measles: Diagnosis
Tuesday 26th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many diagnoses of measles there have been in the last 12 months.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The UK Health Security Agency (UKHSA) publishes routine data on laboratory confirmed measles.

Between 1 January 2023 and 31 December 2023, there have been 368 laboratory confirmed cases in the England. From 1 October 2023, there have been 730 laboratory confirmed measles cases reported in England.

The 2023 data is available at the following link:

https://www.gov.uk/government/publications/measles-epidemiology-2023/confirmed-cases-of-measles-in-england-by-month-age-and-region-2023

As part of the national incident response, 2024 data is currently being published weekly at the following link:

https://www.gov.uk/government/publications/measles-epidemiology-2023/national-measles-standard-incident-measles-epidemiology-from-october-2023


Written Question
Asthma
Tuesday 26th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what guidance her Department plans to issue to asthmatic people on projected high pollen levels this summer.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

At present, NHS England has no plans to issue guidance to asthmatic people on projected high pollen levels this summer. However, the National Health Service website contains advice on asthma, which includes advice on understanding and managing triggers, such as pollen. The NHS site also links to Asthma and Lung UK’s advice on asthma management, which contains more detailed information on managing triggers, and how best to reduce risk when pollen levels are high.

The UK Health Security Agency (UKHSA) has new capabilities for monitoring real-time pollen levels for this year’s pollen season. This adds to the UKHSA’s Real-time Syndromic Surveillance, which includes the monitoring of presentations of asthma to the NHS. The UKHSA also provides weekly updates via publicly available surveillance bulletins, which are available at the following link:

https://www.gov.uk/government/collections/syndromic-surveillance-systems-and-analyses.

In addition to this work, the Met Office provides alerts and advice when pollen levels are high. These alerts provide valuable information on pollen levels over the next five days for asthmatics and hayfever sufferers, so they can appropriately modify their planned future activities, and ensure they use or have their medication with them.


Written Question
Electronic Cigarettes: Children
Wednesday 20th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the (a) prevalence of the use of disposable vapes by people under the age of 18 and (b) impact of that use on their health.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Vaping is never recommended for children and carries the risk of future harm and addiction. The active ingredient in most vapes, apart from nicotine-free vapes, is nicotine which, when inhaled, is a highly addictive drug. Evidence suggests that the brain in adolescence is more sensitive to the effects of nicotine, so there could be additional risks for young people. The long-term health harms of colours and flavours when inhaled are unknown, but they are certainly very unlikely to be beneficial.

The Department does not hold data on the prevalence of the use of disposable vapes by people under the age of 18 years old. However, Action on Smoking and Health’s survey, Use of e-cigarettes among young people in Great Britain, found that 69% of vape users aged 11 to 17 years old mainly used disposable vapes in 2023, rising from 7.7% in 2021. Northern Ireland’s Young person’s behaviour and attitude survey 2022, shows that 85.7% of 11 to 16 year olds in Northern Ireland who currently use vapes, reported that they used disposables. Both surveys are available respectively at the following links:

https://ash.org.uk/resources/view/use-of-e-cigarettes-among-young-people-in-great-britain

https://www.health-ni.gov.uk/publications/young-persons-behaviour-and-attitudes-survey-2022-substance-use-data-tables


Written Question
Cot Deaths
Monday 18th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to raise awareness of what can be done to prevent Sudden Infant Death Syndrome.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Prevention and early intervention are paramount to preventing Sudden Infant Death Syndrome (SIDS), and we want to ensure that every family receives the support and guidance they need during the early days of parenthood.

Health visitors have an important role supporting child health, wellbeing, and parenting confidence. They support families in improving health literacy, managing minor illnesses, and preventing accidents, including promoting safe sleeping for babies. Health visitors can also work with early years services to ensure that safer sleep messages are promoted across early years services. Further information is available at the following link:

https://www.gov.uk/government/publications/commissioning-of-public-health-services-for-children/early-years-high-impact-area-5-improving-health-literacy-managing-minor-illnesses-and-reducing-accidents

The Department is also working alongside NHS England and the National Child Mortality Database (NMCD) to increase the data bank on SIDS, to increase our evidence base, understanding, and inform actions and policy.


Written Question
Long Covid
Monday 18th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of people with long covid.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government does not currently routinely record the total number of people with long COVID, or new cases identified. However, the most recent data from the Office of National Statistics (ONS) shows that for the four week period ending 5 March 2023: 1.9 million people, or 2.9% of the population, in private households in the United Kingdom reported experiencing long COVID symptoms; 83,000 people first had, or suspected they had, COVID-19 less than 12 weeks previously; 1.73 million people had symptoms for 12 or more weeks, 1.3 million people for at least a year and 762,000 for at least two years; and 1.5 million people reported day-to-day activities adversely affected. Of these, 381,000 people reported that their ability to undertake day-to-day activities had been limited a lot.

On 25 April 2024, the ONS will be publishing additional analysis from the fortnightly Winter Coronavirus (COVID-19) Infection Study, including data on trends in ongoing symptoms of COVID-19. This article will expand on the existing analysis published in the Winter Coronavirus (COVID-19) Infection Study’s data tables, to look more in depth at trends in self-reported symptoms of COVID-19, including ongoing symptoms and associated risk factors.


Written Question
Dental Services: Northern Ireland
Thursday 14th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions she has had with the Department of Health in Northern Ireland on NHS dental provision.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

On 13 December 2023, I met with the Ministers and officials from across the four nations to discuss dentistry provision. There was an agreement to continue to work on a United Kingdom-wide basis for international recruitment initiatives. The Permanent Secretary of Northern Ireland's Department of Health, alongside Government officials, was present for the meeting. The Government's Chief Dental Officer for England also meets regularly with his counterparts in the devolved administrations.


Written Question
Cancer: Screening
Wednesday 13th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what her expected timescale is for the availability of the Galleri blood test in cancer testing and diagnosis across the NHS.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The NHS-Galleri trial is looking into the use of a new blood test to see if it can help the National Health Service to detect cancer early, when used alongside existing cancer screening. The trial recruited the target of 140,000 participants, and interim results are expected in spring or summer 2024.

If the trial is successful, the NHS has committed to rolling out up to one million Galleri tests in 2024 and 2025, as part of an interim implementation pilot. The clinical trial is currently planned to conclude in 2025, with results expected in 2026.

Should the final results be positive, the UK National Screening Committee (UK NSC) may consider the use of the test in a national screening programme. A UK NSC-recommended national screening programme would need to consider the effectiveness of the test, balancing the risk of false positives and unnecessary invasive treatments, against potential early detection.


Written Question
HIV Infection: Screening
Wednesday 13th March 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps her Department has taken to encourage people to be tested for HIV.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

The HIV Action Plan is the cornerstone of our approach to drive forward progress and achieve our goal of ending new HIV transmissions, AIDS, and HIV-related deaths within England by 2030. A key principle of our approach is to ensure that all populations benefit equally from improvements made in HIV outcomes, including through testing.

As part of the HIV Action Plan, the Department is investing over £4.5 million from 2021 to 2025 to deliver the HIV Prevention Programme, a nationally co-ordinated programme of HIV prevention work that is designed to complement locally commissioned prevention activities, in areas of high HIV prevalence and for communities at risk of HIV transmission. The programme also aims to improve knowledge and understanding of HIV transmission and reduce stigma within affected communities through the delivery of public campaigns such as National HIV Testing Week, and evidence-based HIV prevention interventions in partnership with local organisations and charities. During National HIV Testing Week this year, we dispatched over 24,000 kits.

As an additional part of the HIV Action Plan, NHS England has expanded opt-out HIV testing in 34 emergency departments in local areas in England with extremely high HIV prevalence and the whole of London, including some areas with high HIV prevalence. This programme began in 2022 and is funded by NHS England, with £20 million until the end of March 2025. In the first 21 months, the programme has preliminarily identified 685 people newly diagnosed with HIV, and 384 people previously diagnosed with HIV but not in care.

Given the success of the programme, the Department has committed an additional £20 million for new research, which will involve an expansion and evaluation of opt-out blood borne virus testing, including for HIV, in 47 additional emergency departments in local areas with high HIV prevalence across England. Funding will support 12 months of testing for each emergency department, to begin in April 2024, although it is at the discretion of individual sites when the testing will commence.